PhaseBio Pharmaceuticals, Inc. (PHAS)

Total Costs & Expenses

-$13.05M

TTM · Period ending: · USD

PHAS logo

PHAS Total Costs & Expenses

Latest reported-$13.05M
PHAS Total Costs & Expenses ($9.50M → -$13.05M)
High-resolution chart · PNG

PHAS total costs & expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

PhaseBio Pharmaceuticals, Inc. Total Costs & Expenses — Annual fiscal periods (USD)
Period endingTotal Costs & Expenses (USD)
118,193
85,176,000
42,097,000
20,312,000
8,538,000
9,501,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.